Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000163928 | SCV000214523 | likely benign | Hereditary cancer-predisposing syndrome | 2014-09-09 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV000206632 | SCV000261613 | likely benign | Ataxia-telangiectasia syndrome | 2024-01-30 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000163928 | SCV000681968 | likely benign | Hereditary cancer-predisposing syndrome | 2015-07-22 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000587079 | SCV000694178 | likely benign | not specified | 2020-11-06 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001541536 | SCV001759550 | benign | not provided | 2015-05-05 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001541536 | SCV002050042 | likely benign | not provided | 2021-08-06 | criteria provided, single submitter | clinical testing | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV001541536 | SCV004219936 | likely benign | not provided | 2021-12-17 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV004589737 | SCV005083552 | benign | Familial cancer of breast | 2024-04-26 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |
Natera, |
RCV000206632 | SCV002090934 | likely benign | Ataxia-telangiectasia syndrome | 2020-03-27 | no assertion criteria provided | clinical testing |